Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Biocon to set up...

    Biocon to set up research and development unit in Telangana

    Written by Ruby Khatun Khatun Published On 2018-02-25T12:30:10+05:30  |  Updated On 25 Feb 2018 12:30 PM IST
    Biocon to set up research and development unit in Telangana

    Hyderabad: Biopharmaceuticals firm Biocon will soon start a research and development (R&D) lab of its subsidiary Syngene in Genome Valley in Telangana, which is expected to generate 1,000 high-tech jobs, the state government said.


    The company will also be expanding its current presence in Hyderabad on APIs (Active Pharmaceutical Ingredients/ Intermediates) to add 500 new jobs, it added.


    Biocon MD Kiran Mazumdar-Shaw met Telangana IT and Industries Minister K T Rama Rao on the sidelines of BioAsia 2018 and informed the minister about Biocon's decision to expand their operations in Telangana, the statement said.


    A business delegation headed by Chutima Bunyapraphasara, Deputy Minister of Commerce, Thailand, also met Rao on the sidelines of BioAsia 2018.




    Further, Italian Consul General in Mumbai, Stefania Costanza, informed Rao that a delegation of the Italian Chamber of Commerce will soon visit Telangana to explore business opportunities, the statement added.


    The minister also met Terri Bresenham, CEO & President, Sustainable Healthcare Division, GE. The GE team expressed interest in collaborating with the Telangana Academy of Skill & Knowledge (TASK) in healthcare skilling, the release added.

    active pharmaceutical ingredientsAPIsBioAsia 2018BioconChutima BunyapraphasaraGenome ValleyHyderabadIT and Industries MinisterK T Rama RaoKiran Mazumdar Shawresearch and development unitStefania CostanzaSyngeneTelangana
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok